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Objectives: Overweight and obesity have been identified
as risk factors for sexual dysfunction. However, this
relationship has not been well documented in women,
and the results have been conflicting, perhaps because of
the complexity of female sexuality. The aim of our study
was to determine the prevalence of and factors associated
with female sexual dysfunction (FSD) and its subtypes
among overweight and obese women.
Methods: This cross-sectional study was conducted from
January to June 2012 atKlinikRawatanKeluargaHospital
Universiti SainsMalaysia. A validatedMalay version of the
Female Sexual Function Index was administered to 204
overweight and obese women. The socio-demographics and
physical and biochemical parameters were obtained. Mul-
tiple logistic regression was used to evaluate the confound-
ing factors for sexual dysfunction.
Results: The prevalence of FSD among overweight and
obese women was reported to be 12.3% (95% CI: 7.79,
16.81). Sexual desire disorder was the most prevalent
dysfunction (23%), followed by arousal disorder (8.3%),
lubrication disorder (9.3%), orgasm disorder (4.9%), satis-
faction disorder (9.3%) and pain disorder (6.9%). Parity
1.08 (1.01, 1.15) and duration of marriage 0.70 (0.50, 0.96)
were significantly associated with FSD in the study cohort.
Conclusions: Sexual dysfunction among overweight and
obese women was low. Parity showed a significant posi-
tive correlation with FSD, while the duration of marriage
appeared to be a protective factor against FSD.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.01.009
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The ability to function sexually contributes to a healthy
sexual life, which in turn sustains a good relationship. How-
ever, sexual function impairment in intimate relationships can
cause discontentment and bitterness. Several definitions and
classifications for female sexual dysfunction (FSD) have been
proposed. The World Health Organization (WHO) defines
sexual dysfunction for an individual as the inability to
participate in a sexual relationship as he or she would wish.1
In the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV), sexual dysfunctions are defined as
disturbances in sexual desire and the psychophysiological
changes that characterize the sexual response cycle, causing
marked distress and interpersonal difficulty.2
The prevalence of FSD among obese women has ranged
from 50% to 86%.3,4 A study by Kolotkin et al. indicated
that higher BMI was associated with higher impairment of
sexual quality of life in women.5 David B et al.
documented that extreme obesity also led to impairment of
quality of life.6 However, few women have come forward
to reveal that they have sexual dysfunction, although it
does affect their self-esteem and quality of life, as well as
causing emotional distress, leading to relationship problems
in their marital lives.7
There are many factors leading to FSD, such as having a
much older husband, being married for too long, having too
many children and reduced intercourse frequency.8 There are
also decreases in sexual desire and frequency of sexual
intercourse during pregnancy, due to physical discomfort,
fatigue, a feeling of unattractiveness and fear of
miscarriage or causing harm to the foetus.9 A number of
medical illnesses can also lead to FSD through various
pathophysiologic changes, including diabetes mellitus,
hypertension, smoking and heart disease.10 Lower
household income11 and stress urinary incontinence12 are
also factors that can lead to FSD.
Obesity increases the incidence of dyslipidaemia and the
prothrombotic state.13 Dyslipidaemia progressively develops
as BMI increases from 21 kg/m2 with an elevation in
proatheromatous, dense, small-particle-sized low density li-
poprotein.13 Diseases can cause reduced genital blood flow
secondary to atherosclerosis of the iliohypogastric or
pudendal arterial bed, causing vaginal wall and clitoral
smooth muscle fibrosis and resulting in vaginal dryness,
dyspareunia and impaired sexual arousal.10
Hormonal balances are also an important factor in
maintaining normal female sexual function. Oestradiol is a
predominant female sex hormone that contains oestrogen,
and it maintains vaginal mucosal epithelium integrity, which
improves lubrication and increases vaginal sensation.9,14 Italso has vasodilatory and vasoprotective effects on the
vagina.14 The beneficial effects of oestrogen enhance sexual
arousal. In postmenopausal women, oestrogen replacement
therapy has been proved to improve vaginal lubrication, as
well as female sexual desire.15
Testosterone, an androgen predominant in women, plays
an important role in libidoand sexual desire, influencing sexual
activity initiation and permission for sexual behaviour.16
Testosterone also enhances vaginal lubrication and facilitates
smooth vaginal muscle relaxation. The androgens also play
roles in the development of reproductive function and in
secondary sexual characteristic growth and maintenance by
modulating the vaginal and clitoral physiology.16 Treatment
with testosterone in surgically menopausal women improved
clitoral sensitivity, sexual desire, arousal and satisfaction.14
In addition, it also caused improvements in energy, well-
being and psychological symptoms.16
The incidence of sexual dysfunction has been noted to be
higher among overweight and obese women, compared to
the general population. This problem can negatively affect
physical and emotional well-being, which subsequently can
impair the general health of affected persons. However, no
local data could be found showing the severity of the prob-
lem; the available literature has come mainly from Western
studies. By studying the FSD problem among local women,
it will hopefully assist doctors in providing appropriate in-
terventions or assistance. Thus, this study was performed to
determine the prevalence of FSD and its associated factors
among local overweight and obese women, as well as the
subtypes of FSD problems in this group.
Materials and Methods
A cross-sectional study was conducted for a period of 6
months from January to June 2012 at Klinik Rawatan
Keluarga (KRK), Hospital Universiti Sains Malaysia
(HUSM).
Participants
A total of 204 patients participated in this study, using a
single proportion formula based on a study performed in
Turkey.4 The study power was 80%, after considering a 10%
dropout rate. The inclusion criteria were female sex, age of 18
years old or old, body mass index (BMI) 25 kg/m2 and
greater, married with heterosexual relationship and regular
menses. The exclusion criteria were pregnancy, menopause,
patients who came for follow-ups for chronic illnesses, such
as diabetes mellitus, stroke, heart failure, and end stage renal
disease, chronic immobilization, known psychiatric illnesses,
such as schizophrenia, depression, and anxiety disorders,
known gynaecological problems, such as pelvic trauma,
genital prolapse, and lower genital tract abnormalities, active
genitourinary infection and the use of oral contraceptive
pills.
Assessment of sexual function
The Malay Version of the Female Sexual Function Index
(MVFSFI) was developed and validated by Sidi et al. in
married female patients who attended a primary health care
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MVFSFI is a validated self-reported questionnaire that has
been shown to have discriminate reliability between women
with and without FSD. The sensitivity and specificity of the
MVFSFI are 99% and 97%, respectively, with a Cronbach’s
ɑ ranging from 0.8665 to 0.9675. Sensitivity and specificity
values for each domain were also established; they were 95%
and 89%, respectively, for sexual desire disorder, 77% and
95%, respectively, for arousal disorder, 79% and 87%,
respectively, for lubrication disorder, 83% and 85%,
respectively, for orgasm disorder, 83% and 85%, respec-
tively, for satisfaction disorder, and 86% and 95%, respec-
tively, for sexual pain disorder.
The MVFSFI is a translated version of the original Fe-
male Sexual Function Index (FSFI), which was developed by
Rosen et al. in the United States.18 The questionnaire has 19
items assessing the participant’s sexual function during the
previous four weeks prior to enrolment. It categorizes
sexual dysfunction into six basic domains: desire, arousal,
lubrication, orgasm, satisfaction and sexual pain.
For each question, there are five to six options available,
for which the most likely answer is chosen by the participants
to represent their sexual function in the preceding four
weeks. Each answer is scored ranging from 0 to 5. The lower
the score is, the higher the probability is of having the
respective female sexual dysfunction (Table 1). A total score
of 55 was used as the cut-off point for the MVFSFI to
differentiate between women with and without sexual
dysfunction. For each domain, women who scored less than
the cut-off point were indicated to have that specific domain
disorder and vice versa.
Anthropometric measurements and laboratory analyses
The height and weight of the participants were measured
using a calibrated Seca scale, with the participants wearing
light-weight clothing without shoes. Body mass index (BMI)
was calculated as weight in kilogrammes divided by the
square of height in metres (kg/m2). The measurements were
recorded in the participants’ case report forms. BMI of
25 kg/m2 is considered overweight, while obesity is indi-
cated by BMI 30 kg/m2.19
A total of 5 ml of fasting venous blood was obtained to
measure serum testosterone, fasting blood sugar and fasting
lipid profiles. The venous blood was obtained in the morning
before 10.00 am to maximize the accuracy of the serumTable 1: FSFI scoring for each domain.
Sexual
function
domain
Item
number
Score
range
Minimum
score
Maximum
score
Cut-off
point
Desire 1,2 1e5 2 10 5
Arousal 3,4,5,6 0e5 0 20 9
Lubrication 7,8,9,10 0e5 0 20 10
Orgasm 11,12 0e5 0 10 4
Satisfaction 13,14,15,16 0/1e5a 2 20 11
Pain 17,18,19 0e5 0 15 7
Total 1e19 4 95 55
a Range for item 14 ¼ 0e5; range for items 15 and 16 ¼ 1e5.testosterone level because androgens undergo a diurnal
variation, in which the levels are highest in the morning. The
blood was sent to a private laboratory for analysis.Data collection procedure
Using convenience sampling, eligible overweight and
obese women were identified and approached by the
researcher during their visits to KRK, HUSM, for various
medical reasons. Explanations were provided regarding the
study, and the women were reassured that the gathered in-
formation was kept confidential. Their BMIs were measured,
and if they fulfilled the inclusion and exclusion criteria, a set
of guided self-administered MVFSFI questionnaires was
provided, and venous blood samples were drawn. The par-
ticipants had to complete the questionnaire on the same day.
The participants were provided with another appointment
date for blood to be drawn if they had come in after 10.00 am
or were non-fasting.Statistical analysis
Data entry and analyses were performed by using the
Statistical Package for the Social Sciences (SPSS) software,
version 22. The numerical variables are expressed as the
means and standard deviations. Regarding categorical vari-
ables, the frequency and percentage were calculated. The chi-
square test was used for comparison of types of FSD between
overweight and obese women. Simple logistic regression was
used to screen for factors potentially associated with FSD,
and multiple logistic regression was used to determine the
factors associated with FSD while adjusting for other con-
founders in the model. The dependent variable was FSD.
The independent variables were age, race, education level,
employment, monthly family income, husband’s age, hus-
band’s medical illnesses, duration of marriage, frequency of
sexual intercourse, parity, BMI, serum testosterone, fasting
blood sugar (FBS), total cholesterol (TC) level, low-density
lipoprotein cholesterol (LDL) level, triglyceride (TG) level
and high-density lipoprotein cholesterol (HDL) level.Results
A total of 212 overweight and obese participants were
screened for eligibility. However, 8 of them were not eligible
due to not fasting and being unable to come again to KRK.
Therefore, only 204 participants were recruited and
completed the study for a response rate of 100%. The mean
age of the study subjects was 39 years old. The participants
were mainly Malay (95.6%) and employed (85.3%) and had
non-tertiary educational levels (75%). The distribution of
BMI was skewed to the right with a median (IQR) of 29.5
(6.05) kg/m2. The socio-demographic and clinical charac-
teristics of the participants are summarized in Table 2.
Of the 204 participants, a total of 25 participants had
FSD, with prevalence of 12.3% (95%CI: 7.79, 16.81). Sexual
desire was the most common problem reported by the par-
ticipants (23%), compared to the other types of FSD
(Table 3).
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orders were noted to have significant associations with the
overweight and obese groups (Table 4).
Comparison of the socio-demographic data, marital sta-
tus, husband’s age and clinical characteristics between the
participants with and without FSD are shown in Table 5. No
significantly associated factors were noted in simple logistic
regression analysis (Table 6). Multiple logistic regression
analysis showed that parity was a significantly positive
associated factor, while duration of marriage was a
significantly negative associated factor with FSD (Table 7).Discussion
Sexuality and intimacy are essential elements of a marital
relationship. Good sexual quality of life contributes to
physical, as well as psychosocial and emotional, well-being.
An intimate relationship provides a feeling of security and
balance, and it also provides support during times of
distress.20 Most overweight and obese people considerTable 2: Socio-demographic and clinical characteristics of
participants (n[ 204).
Variables Mean (SD)a n (%)
Age (year) 39.0 (8.22)
Monthly family income (RM) 3000 (2000)b
Race
Malay 195 (95.6)
Non-Malay 9 (4.4)
Education level
Tertiary 51 (25.0)
Non-tertiary 153 (75.0)
Employment
Employed 174 (85.3)
Unemployed 30 (14.7)
Marital and husband characteristics
Marriage duration (years) 14.9 (8.91)
Parity 3.1 (1.86)
Husband’s age (years) 42.4 (8.98)
Frequency of sexual intercourse
3/week 23 (11.3)
1e2/week 124 (60.8)
3/month 57 (27.9)
Husband with medical illness
Yes 53 (26.0)
No 151 (74.0)
Clinical characteristics
BMI (kg/m2) 29.5 (6.05)b
Overweight 113 (55.4)
Obese 91 (44.6)
Serum testosterone (nmol/L) 1.2 (0.08)b
FBS (mmol/L) 4.7 (0.90)b
TC(mmol/L) 5.5 (1.01)
TG(mmol/L) 1.2 (0.68)b
LDL(mmol/L) 3.5 (0.84)
HDL(mmol/L) 1.5 (0.29)
Abbreviations: BMI¼Body mass index; FBS¼Fasting blood
sugar; TC ¼ Total cholesterol; TG ¼ Triglyceride; LDL ¼ Low
density lipoprotein; HDL¼High density lipoprotein.
a Standard deviation.
b Median (interquartile range).themselves to be less attractive, less sexually interesting and
incapable of developing a satisfying romantic relationship,
compared to people with normal weight.20 Therefore, they
have a higher risk of developing sexual dysfunction,
compared to women with normal weight.
The present study revealed a prevalence of 12.3% (95%
CI: 7.79, 16.81) of women with FSD among overweight and
obese premenopausal women who attended a hospital-based
primary care clinic, according to the MVFSFI. The preva-
lence observed in this study was far lower than that reported
in the Turkish population. A study conducted by Yaylali
et al. among premenopausal, otherwise-healthy overweight
and obese Turkish women using the FSFI revealed that 86%
of them had FSD.4 The mean BMI of the participants in
Yaylali et al.’s study was higher than in the present study,
at 37.5 (9.1) kg/m2 compared 29.5 (6.05) kg/m2 in our study.4
Another Turkish study performed among 64 healthy
premenopausal obese women using the FSFI found the
prevalence of FSD to be 50%.3 However, in this study, only
obese women with BMIs of 30 kg/m2 or greater were
recruited, while in the present study, overweight women
with BMIs of 25 kg/m2 were also included. In both Turkish
studies, the sample sizes are relatively smaller than in this
study, which might explain the difference in the prevalence
of sexual dysfunction. The numbers of participants studied
by Yaylali et al.4 and Kadioglu et al.3 were 45 and 64,
respectively, while in the present study, the total number of
subjects was more than two fold greater, at 204 women.
The difference in prevalence rates between the previous
and present studies might be due to the difference in cut-off
points used for determining FSD. In the present study, the
cut-off point used in the MVFSFI to determine FSD was
55, while in the Turkish population studies,3,4 which used
the FSFI, a cut-off point of 26.55 was used for defining
FSD.
In a study conducted by Kolotkin et al., approximately
54.7%e61.2% of obese women reported having sexual
dysfunction at least some of the time.5 However, the type of
questionnaire used to assess sexual dysfunction in that study
was different from the present study. Kolotkin et al.Table 3: Types of sexual dysfunction among participants.
Types FSD No FSD n (%)
Desire disorder
Yes 20 (80.0) 27 (15.1) 47 (23.0)
No 5 (20.0) 152 (84.9) 157 (77.0)
Arousal disorder
Yes 17 (68) 0 (0.0) 17 (8.3)
No 8 (32) 179 (100.0) 187 (91.7)
Lubrication disorder
Yes 16 (64) 3 (1.7) 19 (9.3)
No 9 (36) 176 (98.3) 185 (90.7)
Orgasm disorder
Yes 9 (36) 1 (0.6) 10 (4.9)
No 16 (64) 178 (99.4) 194 (95.1)
Satisfaction disorder
Yes 15 (60.0) 4 (2.2) 19 (9.3)
No 10 (40.0) 175 (97.8) 185 (90.7)
Sexual pain disorder
Yes 9 (36.0) 5 (2.8) 14 (6.9)
No 16 (64.0) 174 (97.2) 190 (93.1)
Table 4: Types of sexual dysfunction among overweight and
obese patients.
Variable Overweight n (%) Obese n (%) p valuea
Desire disorder
Yes 26 (23.0) 21 (23.1) 0.991
No 87 (77.0) 70 (76.9)
Arousal disorder
Yes 8 (7.1) 9 (9.9) 0.470
No 105 (92.9) 82 (90.1)
Lubrication disorder
Yes 7 (6.2) 12 (13.2)
No 106 (93.8) 79(86.8) 0.080
Orgasm disorder
Yes 5 (4.4) 5 (5.5) 0.730
No 108 (95.6) 86 (94.5)
Satisfaction disorder
Yes 5 (4.4) 14 (15.4) 0.007
No 108 (95.6) 77 (84.6)
Sexual pain disorder
Yes 3 (2.7) 11 (12.1) 0.008
No 110 (97.3) 80 (87.9)
a Chi-square.
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ofWeight on Quality of Life-Lite questionnaire. Sexual life is
part of the quality of life evaluated on the questionnaire, and
it is assessed by four items: sexual enjoyment, sexual desire,
sexual performance and sexual avoidance,5 whereas in this
present study, the MVFSFI was used, which has more
questions and undertakes a more extensive assessment of
female sexual function, for example, assessment of pain
during sexual intercourse.
Different sociodemographic backgrounds and cultural
beliefs of the participants might also have contributed to the
different findings regarding the prevalence of FSD. In the
present study, although the participants were sexually active,
with more than half having at least 1 to 2 episodes of sexual
intercourse per week, they might not have been ready to
disclose their sexual problems to other people because
sexuality is still considered a taboo subject to discuss openly
in Malaysian culture, leading to under-diagnosis of sexual
difficulties. A study performed in Asia showed that, among
patients with sexual dysfunction, nearly half of them did not
seek any help or advice for their sexual problems.21 When
asked about the reason for not consulting a physician,
approximately one-third of them linked it to
embarrassment.21Types of sexual dysfunction in overweight and obese women
The present study showed that approximately one-fourth
(23%) of the subjects had decreased sexual desire, which is
the most frequently reported sexual dysfunction, compared
to other sexual domains. This finding was similar to local
studies performed in general populations by Sidi et al.8 and
Ishak et al.,22 which also found sexual desire disorder to be
the most prevalent FSD condition (69.6% and 39.3%,
respectively). The finding of the highest prevalence for
sexual desire disorder compared to other sexual domains
was also demonstrated by other studies performed invarious countries among non-overweight and obese pop-
ulations, ranging from 22% to 60.3%.11,23e26
Adolfsson et al. reported that obese women aged 18e49
years old experienced the greatest decrease in sexual desire,
compared to a normal weight group.20 Although there
were no differences in sexual dysfunction (lack of sexual
desire, arousal problems, painful intercourse) observed
among overweight, obese and normal-weight women,
Bajos et al. showed a significant trend towards decreasing
sexual desire with increasing BMI.27 Assimakopoulos et al.
reported that severely obese women seeking bariatric
surgery had significant impairments in most sexual
function domains, including sexual desire, arousal,
lubrication, orgasm and satisfaction,28 while a study
performed by Kolotkin et al. among obese women and
men found that approximately 32.8%e37.6% of women
reported that they always or usually had little sexual
desire, experienced sexual performance difficulties, did
not enjoy sexual activity and/or avoided sexual
encounters because of their weight.5
However, our data showed that arousal and lubrication
were significantly associated with overweight and obesity in
patients. This finding was supported by Esposito et al., who
claimed that arousal, lubrication, satisfaction and orgasm
were affected by obesity.29
A study from Iran revealed that, when women were
asked to explain the causes of the sexual disorders from
which they were suffering, most of them linked the prob-
lems to poor partner performance (87%) and the partner’s
sexual dysfunction (82%).30 Fugl-Meyer and Fugl-Meyer
demonstrated that women with partners suffering from
erectile dysfunction had a higher incidence of sexual
problems, including lack of sexual interest, inadequate
lubrication and orgasmic difficulty, compared to the gen-
eral community.31 Another study conducted in Turkey
found that women whose partners had erectile
dysfunction had significant lower scores in total and on
all sexual domains except for sexual desire, compared to
those with a healthy partner.23Factors associated with female sexual dysfunction
In this study, two factors were found to be associated
significantly with sexual dysfunction among overweight and
obese women. These factors were parity and duration of
marriage.
A finding from this study showed that higher parity was
associated with FSD, and women with higher parity were
more likely to have FSD. Previous studies of FSD among
overweight and obese women do not include parity or
number of children as a variable when examining potentially
associated factors. The existing studies have indicated that
women with greater numbers of children reported a higher
incidence of sexual dysfunction.8,30 This finding was
supported by Witting K et al., who noted that multiparous
women had fewer orgasm and pain problems and were
sexually more satisfied than nulliparous women.32
The results of our study also showed a significant, nega-
tive association of FSD with longer duration of marriage.
Those who have longer marriages were less likely to have
FSD. Longer duration of marriage is an indication of
Table 5: Sociodemographic, marital, spousal and clinical characteristics of participants with and without sexual dysfunction.
Variables FSD (n ¼ 25) Non-FSD (n ¼ 179)
Mean (SD)a n (%) Mean (SD)a n (%)
Sociodemographic characteristics
Age (year) 40.6 (9.61) 38.8 (8.01)
Monthly family income (RM) 3146.9 (2436.55) 3384.2 (2185.52)
Race
Malay 23 (92.0) 172 (96.1)
Non-Malay 2 (8.0) 7 (3.9)
Education level
Tertiary 6 (24.0) 45 (25.1)
Non-tertiary 19 (76.0) 134 (74.9)
Employment
Employed 22 (88.0) 152 (84.9)
Unemployed 3 (12.0) 27 (15.1)
Marital and spousal characteristics
Marriage duration (years) 16.8 (9.96) 14.7 (8.75)
Parity 2.8 (1.41) 3.2 (1.91)
Husband’s age (years) 44.7 (10.37) 42.1 (8.76)
Frequency of sexual intercourse
3/week 1 (4.0) 22 (12.3)
1e2x/week 9 (36.0) 115 (64.2)
3/month 15 (60.0) 42 (23.5)
Husband with medical illness
Yes 9 (36.0) 44 (24.6)
No 16 (64.0) 135 (75.4)
Clinical characteristics of participants
BMI (kg/m2) 29.6 (3.21) 30.6 (4.57)
Overweight 12 (48.0) 101 (56.4)
Obese 13 (52.0) 78 (43.6)
Serum testosterone (nmol/L) 1.3 (0.62) 1.3 (0.70)
FBS (mmol/L) 4.7 (0.69) 4.8 (0.69)
TC (mmol/L) 5.5 (0.91) 5.5 (1.03)
TG (mmol/L) 1.2 (0.37) 1.3 (0.61)
LDL (mmol/L) 3.5 (0.75) 3.5 (0.86)
HDL (mmol/L) 1.4 (0.24) 1.5 (0.29)
Abbreviations: BMI¼Body mass index; FBS¼Fasting blood sugar; TC ¼ Total cholesterol; TG ¼ Triglyceride; LDL ¼ Low density
lipoprotein; HDL¼High density lipoprotein.
a Standard deviation.
A. Abidin et al.164relationship stability; couples spend more time together in
leisure and religious activities.33 Hence, they are more
acquainted with each other’s preferences, including sexual
preferences34. However, in Ishak et al.’s study, the results
showed that duration of marriage was not significantly
associated with FSD.22 Their study was undertaken among
women attending a primary care clinic in Kuala Lumpur.
The different in result was probably due to the high
prevalence of FSD (25.8%) noted in their study compared
to our study (12.3%), and the study population was also
different despite the use of a similar questionnaire. At the
same time, in another study conducted in Egypt, Zakia
et al. reported that the duration of marriage was
significantly associated with FSD. These authors reported
that the women with FSD in their study experienced
marital disharmony and had difficult economic and/or
social lives.35
In this study, obesity and BMI did not show significant
associations with FSD. This result was in accordance with
the study by LM Nackers et al. They concluded that, despite
BMI increases, there was no association with changes insexual functioning, sexual desire or intercourse frequency.36
Another recent study also supported our findings.37
In contrast, Kirchengast et al. reported that obesity was
associated with reduced sexual interest. The dissimilarity in
findings occurred because their subjects were menopausal
women, and in menopause, fat deposits tend to increase in
the chest, waist and hip areas.38 In contrast, a study by
Kolotkin et al. claimed that higher BMI was associated
with greater impairment of sexual quality of life in women,
such as lack of enjoyment, little desire, difficulty with
performance and avoidance of sexual encounters. These
authors, however, measured sexual quality using the
Impact of Weight on Quality of Life-Lite questionnaire.5
Other studies in overweight and obese women linking
FSD to measured lipid profiles have been scarce. Athero-
sclerosis causes clitoral and vaginal vascular insufficiency,
leading to vaginal dryness, dyspareunia and impaired sexual
arousal, which subsequently result in female sexual
dysfunction.10 Total cholesterol (TC) is distributed primarily
among three major lipoprotein classes e very-low-density
lipoprotein (VLDL), LDL and HDL e and in smaller
Table 6: Associated factors for FSD among participants using simple logistic regression.
Variables SLRa
B Crude OR (95% CI) Walf (df) p value
Age (years) 0.03 1.03 (0.98, 1.08) 1.05 (1) 0.306
Monthly family income (RM) 0.00 1.00 (1.00, 1.00) 0.25 (1) 0.615
Race
Malay 1.00
Non-Malay 0.76 2.14 (0.42, 10.91) 0.83 (1) 0.361
Education level
Non-tertiary 1.00
Tertiary 0.06 0.94 (0.35, 2.50) 0.015 (1) 0.902
Employment
Employed 1.00
Unemployed 0.26 0.77 (0.22, 2.74) 0.17 (1) 0.684
Marriage duration (years) 0.03 1.03 (0.98, 1.08) 1.23 (1) 0.267
Husband’s age 0.03 1.03 (0.99, 1.08) 1.84 (1) 0.175
Parity 0.12 0.90 (0.71, 1.13) 0.83 (1) 0.362
Frequency of sexual intercourse
3/week 1.00
1e2x/week 0.54 1.72 (0.21, 14.28) 0.25 0.615
3/month 2.06 7.86 (0.97, 63.46) 3.74 0.053
Husband with medical illness
No 1.00
Yes 0.55 1.73 (0.71, 4.18) 1.46 (1) 0.227
BMI (kg/m2) 0.05 0.95 (0.85, 1.05) 0.95 (1) 0.303
Overweight 1.00
Obese 0.34 0.71 (0.31, 1.65) 0.63 (1) 0.429
Serum Testosterone (nmol/L) 0.03 0.97 (0.52, 1.79) 0.01 (1) 0.919
FBS (mmol/L) 0.29 0.75 (0.39, 1.42) 0.79 (1) 0.373
TC (mmol/L) 0.07 0.93 (0.61, 1.42) 0.12 (1) 0.732
TG (mmol/L) 0.56 0.57 (0.24, 1.37) 1.59 (1) 0.208
LDL(mmol/L) 0.70 1.07 (0.65, 1.76) 0.07 (1) 0.785
HDL (mmol/L) 0.61 0.55 (0.12, 2.53) 0.60 (1) 0.439
Abbreviations: BMI¼Body mass index; FBS¼Fasting blood sugar; TC ¼ Total cholesterol; TG ¼ Triglyceride; LDL ¼ Low density
lipoprotein; HDL¼High density lipoprotein.
a Simple logistic regression.
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density lipoprotein (IDL) and lipoprotein (a) {Lp (a)}.39 In
addition to LDL and VLDL cholesterols, IDL and Lp (a)
are also atherogenic.39 However, in our study, they showed
no significant associations with FSD. Similarly, a study by
Esposito K et al. showed no significant association between
TC and FSD.29 The study was undertaken to determine the
relationships of body weight and body fat distribution with
sexual function in women.
In the present study, we found no significant association
between serum testosterone and FSD. This finding was in
agreement with a study by Yaylali et al., who assessedTable 7: Associated factors for FSD among participants using multi
Variable MLRa
B SE of B A
Parity 0.074 0.03 1
Duration of marriage 0.366 0.168 0
There were no significant interactions between the significant independ
Lemeshow goodness-of-fit test was not significant (p value 0.273), show
classification table of 87.7% and an area under the ROC curve of 0.63
a Backward LR multiple logistic regression model was applied.FSD among overweight and obese women in Turkey using
the FSFI questionnaire, finding no significant association
between total testosterone and total FSFI score.4 The
findings of the present study were also supported by
another study from Turkey among premenopausal, obese
women, indicating that total testosterone had no effect
on FSD.3
The present study, however, did have some limitations.
The study population consisted of patients from a hospital-
based primary care clinic. Thus, the results might not
represent the sexual function of the entire population. The
study only included married women with sexuallyple logistic regression.
djusted OR (95% CI) Wald stat (df) p value
.08 (1.01, 1.15) 5.60 (1) 0.018
.70 (0.50, 0.96) 4.77 (1) 0.029
ent variables and no multicollinearity problem. The Hosmer and
ing that the model fit. The model fitness was also supported by the
6.
A. Abidin et al.166functioning partners, so it might have underestimated the
percentage of FSD in sexually active overweight and obese
women. There was no control group in this study; therefore,
we could not ascertain whether the prevalence of FSD was
lower in obese and overweight women or was merely com-
parable to the normal rate in the population.
Conclusions
The prevalence of sexual dysfunction among overweight
and obese women was 12.3%. Sexual desire disorder was the
most prevalent sexual dysfunction compared to the other
domains. Parity was a significantly associated factor, while
duration of marriage was a protective factor against FSD.
Recommendations
The findings of this study provided a better understanding
of and increased our awareness of the magnitude of FSD
among overweight and obese women. It is recommended that
health care providers, particularly in primary care settings,
initiate and facilitate discussions about these issues by asking
patients a few simple, general questions, such as ‘Are you
satisfied with your sexual relationship?’ or ‘Is there any
problem or concern in your sexual activity that you would like
to raise and discuss?’ as part of the initial screening process. If
a patient appears to have sexual problems, more appropriate
questions based on available questionnaires could be used in
diagnosing FSD.
There should be routine screening for FSD in overweight
and obese women, particularly those with other potential
risk factors for FSD, such as other chronic diseases. Because
female sexual dysfunction is prevalent among obese and
overweight women, this issue could be emphasized in weight
loss programs as an encouragement for weight reduction.
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